ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 209,28
-0,12%
Dow Jones
39 431,51
-0,21%
DAX
18 742,22
-0,08%
Brent Oil
83,255
1,06%
Bitcoin
63 113,99
2,71%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Proteostasis Therapeutics Inc (PTI)

  7. Proteostasis Therapeutics Inc (PTI) Actualités

PTI

Proteostasis Therapeutics (PTI)

Proteostasis Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PTI
DateHeureSourceTitreSymboleSociété
29/06/202313h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTIProteostasis Therapeutics Inc
16/06/202322h35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTIProteostasis Therapeutics Inc
13/06/202316h32Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PTIProteostasis Therapeutics Inc
12/06/202323h01Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:PTIProteostasis Therapeutics Inc
01/06/202322h02Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:PTIProteostasis Therapeutics Inc
11/05/202323h23Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PTIProteostasis Therapeutics Inc
28/04/202323h17Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PTIProteostasis Therapeutics Inc
28/04/202323h16Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:PTIProteostasis Therapeutics Inc
28/04/202323h12Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:PTIProteostasis Therapeutics Inc
21/04/202323h14Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:PTIProteostasis Therapeutics Inc
31/03/202322h11Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PTIProteostasis Therapeutics Inc
14/02/202322h20Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PTIProteostasis Therapeutics Inc
14/02/202322h16Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:PTIProteostasis Therapeutics Inc
10/02/202322h55Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:PTIProteostasis Therapeutics Inc
10/02/202315h10Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PTIProteostasis Therapeutics Inc
23/12/202212h01Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PTIProteostasis Therapeutics Inc
16/12/202220h58Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:PTIProteostasis Therapeutics Inc
16/12/202216h38Edgar (US Regulatory)Sec Staff Action/letter (sec Staff)NASDAQ:PTIProteostasis Therapeutics Inc
06/12/202222h05Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:PTIProteostasis Therapeutics Inc
04/11/202221h53Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:PTIProteostasis Therapeutics Inc
20/12/202122h03Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:PTIProteostasis Therapeutics Inc
17/08/202123h21Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:PTIProteostasis Therapeutics Inc
06/01/202123h29Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:PTIProteostasis Therapeutics Inc
22/12/202016h47PR Newswire (US)Proteostasis Therapeutics, Inc. Stockholders Approve Business Combination with Yumanity Therapeutics, Inc.; Board Sets Revers...NASDAQ:PTIProteostasis Therapeutics Inc
15/12/202013h00GlobeNewswire Inc.Yumanity Therapeutics to Raise $33.6 Million PIPE Contingent on Completion of Reverse Merger with ProteostasisNASDAQ:PTIProteostasis Therapeutics Inc
16/11/202022h15PR Newswire (US)Proteostasis Therapeutics Reports Third Quarter 2020 Financial ResultsNASDAQ:PTIProteostasis Therapeutics Inc
23/09/202022h51Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:PTIProteostasis Therapeutics Inc
25/08/202021h41Business WireALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Proteostasis Therapeutics, Inc.NASDAQ:PTIProteostasis Therapeutics Inc
24/08/202020h14Dow Jones NewsBiotech Startup Yumanity Sets Reverse Merger With ProteostasisNASDAQ:PTIProteostasis Therapeutics Inc
24/08/202013h00PR Newswire (US)Yumanity Therapeutics and Proteostasis Therapeutics Announce Merger AgreementNASDAQ:PTIProteostasis Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:PTI

Dernières Valeurs Consultées

BIT
BRES
Lyxor Stoxx Europe 600 B...
BOV
HBTS6
HABITASUL PNB
BIT
J26827
JP Morgan Structured Pro...
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés